GlassScriptPhysician profile
Colleen M Keyes
NPI 1124167093
$10,144.80
in general payments reported to CMS, 2019-2025
11 companies · $1,515 in 2025
The $1,515 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,684 · 2020: $186 · 2021: $40.42 · 2022: $1,731 · 2023: $4,682 · 2024: $307 · 2025: $1,515.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,998 · Travel and Lodging: $1,768 · Food and Beverage: $1,738.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,997.50 |
| Travel and Lodging | $1,768.19 |
| Food and Beverage | $1,738.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,468.02 | 2019-2025 | Da Vinci Surgical System |
| Cook Incorporated | $2,997.50 | 2023 | Blue Rhino |
| Pulmonx Corporation | $2,835.68 | 2019-2023 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Zephyr Endobronchial Valve |
| Boston Scientific Corporation | $313.69 | 2023-2024 | Ultraflex Esophageal Ng |
| Pinnacle Biologics, INC | $164.97 | 2021-2025 | Photofrin |
| Penumbra, INC. | $129.04 | 2024 | Indigo System |
| Astrazeneca Pharmaceuticals LP | $125.44 | 2023 | Breztri |
| Cook Medical LLC | $65.53 | 2025 | Wayne |
| Olympus America INC. | $44.93 | 2023 | Spiration Valve System |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colleen Keyes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.